ID   KS24-M1
AC   CVCL_E6XJ
RX   PubMed=10359214;
RX   PubMed=15365776;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q0A2I5; Influenza A virus (strain A/Chicken/Pennsylvania/1/1983 H5N2) matrix protein 1 (M1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6X7 ! KS24
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=10359214; DOI=10.1038/sj.cgt.7700054;
RA   Meyer G.C., Batrla R., Rudy W., Meuer S.C., Wallwiener D., Guckel B.,
RA   Moebius U.;
RT   "Potential of CD80-transfected human breast carcinoma cells to induce
RT   peptide-specific T lymphocytes in an allogeneic human
RT   histocompatibility leukocyte antigens (HLA)-A2.1+-matched situation.";
RL   Cancer Gene Ther. 6:282-288(1999).
//
RX   PubMed=15365776; DOI=10.1007/s00262-004-0583-z; PMCID=PMC11034349;
RA   Guckel B., Stumm S., Rentzsch C., Marme A., Mannhardt G.,
RA   Wallwiener D.;
RT   "A CD80-transfected human breast cancer cell variant induces
RT   HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as
RT   well as in vivo.";
RL   Cancer Immunol. Immunother. 54:129-140(2005).
//